While the contribution of HLA class II antigen presentation and CD4+ T cells to GvL effects remains vaguely defined, our findings support their described pivotal role for anti-tumor immunity, as CD4+ T cells exert multiple direct anti-tumor effects and orchestrate CD8+ T cell responses at the same time [29,31,32,33,34]. Here, CD8A is linked to neoplasm.